APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabolomics Mixes and Kits

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Metabolomics Mixes and Kits Market Analysis and Forecast 2026-2032

5 June 2026231 pages

Choose your research edition.

Industry ResearchMetabolomics Mixes and Kits Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabolomics Mixes and Kits Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Metabolomics Mixes and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabolomics Mixes and Kits Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabolomics Mixes and Kits Market Analysis and Forecast 2026-2032231 pages · $4,950 USD

Market perspective

The global Metabolomics Mixes and Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Metabolomics Mixes and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Metabolomics Mixes and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Metabolomics Mixes and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Metabolomics Mixes and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Metabolomics Mixes and Kits include Cambridge Isotope Laboratories, Merck KGaA, Biocrates, Thermo Fisher Scientific, Fluidome and Metabolomix, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Metabolomics Mixes and Kits, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Metabolomics Mixes and Kits, also provides the revenue of main regions and countries. Of the upcoming market potential for Metabolomics Mixes and Kits, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metabolomics Mixes and Kits revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metabolomics Mixes and Kits market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Metabolomics Mixes and Kits revenue, projected growth trends, production technology, application and end-user industry.

Metabolomics Mixes and Kits Segment by Company

Cambridge Isotope Laboratories

Merck KGaA

Biocrates

Thermo Fisher Scientific

Fluidome

Metabolomix

Metabolomics Mixes and Kits Segment by Type

Lipid Metabolism

Amino Acid Metabolism

Carbohydrate Metabolism

Bacterial Metabolism

Other

Metabolomics Mixes and Kits Segment by Application

Biological Companies

Research Institutions

Educational Institutions

Metabolomics Mixes and Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabolomics Mixes and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabolomics Mixes and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabolomics Mixes and Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Metabolomics Mixes and Kits in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Metabolomics Mixes and Kits company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabolomics Mixes and Kits revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metabolomics Mixes and Kits Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lipid Metabolism Major Player Table 3. Amino Acid Metabolism Major Player Table 4. Carbohydrate Metabolism Major Player Table 5. Bacterial Metabolism Major Player Table 6. Other Major Player Table 7. Global Metabolomics Mixes and Kits Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Biological Companies Major Player Table 9. Research Institutions Major Player Table 10. Educational Institutions Major Player Table 11. Metabolomics Mixes and Kits Industry Trends Table 12. Metabolomics Mixes and Kits Industry Drivers Table 13. Metabolomics Mixes and Kits Industry Opportunities and Challenges Table 14. Metabolomics Mixes and Kits Industry Restraints Table 15. Global Metabolomics Mixes and Kits Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Metabolomics Mixes and Kits Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Metabolomics Mixes and Kits Market Share by Region (2021-2026) Table 18. Global Metabolomics Mixes and Kits Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Metabolomics Mixes and Kits Market Share by Region (2027-2032) Table 20. Global Metabolomics Mixes and Kits Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Metabolomics Mixes and Kits Revenue Market Share by Players (2021-2026) Table 22. Global Metabolomics Mixes and Kits Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Metabolomics Mixes and Kits Key Players Headquarters & Area Served Table 24. Global Metabolomics Mixes and Kits Players, Product Type & Application Table 25. Global Metabolomics Mixes and Kits Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Metabolomics Mixes and Kits by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Metabolomics Mixes and Kits Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Metabolomics Mixes and Kits Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Metabolomics Mixes and Kits Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Metabolomics Mixes and Kits Revenue Market Share by Type (2021-2026) Table 32. Global Metabolomics Mixes and Kits Revenue Market Share by Type (2027-2032) Table 33. Global Metabolomics Mixes and Kits Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Metabolomics Mixes and Kits Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Metabolomics Mixes and Kits Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Metabolomics Mixes and Kits Revenue Market Share by Application (2021-2026) Table 37. Global Metabolomics Mixes and Kits Revenue Market Share by Application (2027-2032) Table 38. Cambridge Isotope Laboratories Company Information Table 39. Cambridge Isotope Laboratories Business Overview Table 40. Cambridge Isotope Laboratories Metabolomics Mixes and Kits Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Cambridge Isotope Laboratories Metabolomics Mixes and Kits Product Portfolio Table 42. Cambridge Isotope Laboratories Recent Development Table 43. Merck KGaA Company Information Table 44. Merck KGaA Business Overview Table 45. Merck KGaA Metabolomics Mixes and Kits Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Merck KGaA Metabolomics Mixes and Kits Product Portfolio Table 47. Merck KGaA Recent Development Table 48. Biocrates Company Information Table 49. Biocrates Business Overview Table 50. Biocrates Metabolomics Mixes and Kits Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Biocrates Metabolomics Mixes and Kits Product Portfolio Table 52. Biocrates Recent Development Table 53. Thermo Fisher Scientific Company Information Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific Metabolomics Mixes and Kits Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Thermo Fisher Scientific Metabolomics Mixes and Kits Product Portfolio Table 57. Thermo Fisher Scientific Recent Development Table 58. Fluidome Company Information Table 59. Fluidome Business Overview Table 60. Fluidome Metabolomics Mixes and Kits Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Fluidome Metabolomics Mixes and Kits Product Portfolio Table 62. Fluidome Recent Development Table 63. Metabolomix Company Information Table 64. Metabolomix Business Overview Table 65. Metabolomix Metabolomics Mixes and Kits Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Metabolomix Metabolomics Mixes and Kits Product Portfolio Table 67. Metabolomix Recent Development Table 68. North America Metabolomics Mixes and Kits Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Metabolomics Mixes and Kits Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Metabolomics Mixes and Kits Revenue by Application (2021-2026) & (US$ Million) Table 71. North America Metabolomics Mixes and Kits Revenue by Application (2027-2032) & (US$ Million) Table 72. North America Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. North America Metabolomics Mixes and Kits Revenue by Country (2021-2026) & (US$ Million) Table 74. North America Metabolomics Mixes and Kits Revenue by Country (US$ Million) & (2027-2032) Table 75. Europe Metabolomics Mixes and Kits Revenue by Type (2021-2026) & (US$ Million) Table 76. Europe Metabolomics Mixes and Kits Revenue by Type (2027-2032) & (US$ Million) Table 77. Europe Metabolomics Mixes and Kits Revenue by Application (2021-2026) & (US$ Million) Table 78. Europe Metabolomics Mixes and Kits Revenue by Application (2027-2032) & (US$ Million) Table 79. Europe Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. Europe Metabolomics Mixes and Kits Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Metabolomics Mixes and Kits Revenue by Country (US$ Million) & (2027-2032) Table 82. China Metabolomics Mixes and Kits Revenue by Type (2021-2026) & (US$ Million) Table 83. China Metabolomics Mixes and Kits Revenue by Type (2027-2032) & (US$ Million) Table 84. China Metabolomics Mixes and Kits Revenue by Application (2021-2026) & (US$ Million) Table 85. China Metabolomics Mixes and Kits Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Metabolomics Mixes and Kits Revenue by Type (2021-2026) & (US$ Million) Table 87. Asia Metabolomics Mixes and Kits Revenue by Type (2027-2032) & (US$ Million) Table 88. Asia Metabolomics Mixes and Kits Revenue by Application (2021-2026) & (US$ Million) Table 89. Asia Metabolomics Mixes and Kits Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Metabolomics Mixes and Kits Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Asia Metabolomics Mixes and Kits Revenue by Region (US$ Million) & (2021-2026) Table 92. Asia Metabolomics Mixes and Kits Revenue by Region (US$ Million) & (2027-2032) Table 93. SAMEA Metabolomics Mixes and Kits Revenue by Type (2021-2026) & (US$ Million) Table 94. SAMEA Metabolomics Mixes and Kits Revenue by Type (2027-2032) & (US$ Million) Table 95. SAMEA Metabolomics Mixes and Kits Revenue by Application (2021-2026) & (US$ Million) Table 96. SAMEA Metabolomics Mixes and Kits Revenue by Application (2027-2032) & (US$ Million) Table 97. SAMEA Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. SAMEA Metabolomics Mixes and Kits Revenue by Country (2021-2026) & (US$ Million) Table 99. SAMEA Metabolomics Mixes and Kits Revenue by Country (US$ Million) & (2027-2032) Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Metabolomics Mixes and Kits Image Figure 2. Global Metabolomics Mixes and Kits Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabolomics Mixes and Kits Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lipid Metabolism Image Figure 5. Amino Acid Metabolism Image Figure 6. Carbohydrate Metabolism Image Figure 7. Bacterial Metabolism Image Figure 8. Other Image Figure 9. Global Metabolomics Mixes and Kits Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Metabolomics Mixes and Kits Market Size Share 2021 VS 2025 VS 2032 Figure 11. Biological Companies Image Figure 12. Research Institutions Image Figure 13. Educational Institutions Image Figure 14. Global Metabolomics Mixes and Kits Market Size (US$ Million) & (2021-2032) Figure 15. Global Metabolomics Mixes and Kits Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Metabolomics Mixes and Kits Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Metabolomics Mixes and Kits Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Metabolomics Mixes and Kits Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Metabolomics Mixes and Kits Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Metabolomics Mixes and Kits Revenue Market Share by Type (2021-2032) Figure 22. Global Metabolomics Mixes and Kits Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Metabolomics Mixes and Kits Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Metabolomics Mixes and Kits Revenue Market Share by Application (2021-2032) Figure 25. North America Metabolomics Mixes and Kits Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Metabolomics Mixes and Kits Revenue Share by Type (2021-2032) Figure 27. North America Metabolomics Mixes and Kits Revenue Share by Application (2021-2032) Figure 28. North America Metabolomics Mixes and Kits Revenue Share by Country (2021-2032) Figure 29. United States Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Metabolomics Mixes and Kits Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Metabolomics Mixes and Kits Revenue Share by Type (2021-2032) Figure 34. Europe Metabolomics Mixes and Kits Revenue Share by Application (2021-2032) Figure 35. Europe Metabolomics Mixes and Kits Revenue Share by Country (2021-2032) Figure 36. Germany Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Metabolomics Mixes and Kits Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Metabolomics Mixes and Kits Revenue Share by Type (2021-2032) Figure 46. China Metabolomics Mixes and Kits Revenue Share by Application (2021-2032) Figure 47. Asia Metabolomics Mixes and Kits Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Metabolomics Mixes and Kits Revenue Share by Type (2021-2032) Figure 49. Asia Metabolomics Mixes and Kits Revenue Share by Application (2021-2032) Figure 50. Asia Metabolomics Mixes and Kits Revenue Share by Region (2021-2032) Figure 51. Japan Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Metabolomics Mixes and Kits Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Metabolomics Mixes and Kits Revenue Share by Type (2021-2032) Figure 59. SAMEA Metabolomics Mixes and Kits Revenue Share by Application (2021-2032) Figure 60. SAMEA Metabolomics Mixes and Kits Revenue Share by Country (2021-2032) Figure 61. Brazil Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Metabolomics Mixes and Kits Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Lipid Metabolism
  • Amino Acid Metabolism
  • Carbohydrate Metabolism
  • Bacterial Metabolism
  • Other
Applications
  • Biological Companies
  • Research Institutions
  • Educational Institutions
Companies covered
  • Cambridge Isotope Laboratories
  • Merck KGaA
  • Biocrates
  • Thermo Fisher Scientific
  • Fluidome
  • Metabolomix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Metabolomics Mixes and Kits Market by Type
  3. 1.2.1 Global Metabolomics Mixes and Kits Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lipid Metabolism
  5. 1.2.3 Amino Acid Metabolism
  6. 1.2.4 Carbohydrate Metabolism
  7. 1.2.5 Bacterial Metabolism
  8. 1.2.6 Other
  9. 1.3 Metabolomics Mixes and Kits Market by Application
  10. 1.3.1 Global Metabolomics Mixes and Kits Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Biological Companies
  12. 1.3.3 Research Institutions
  13. 1.3.4 Educational Institutions
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Metabolomics Mixes and Kits Market Dynamics
  1. 2.1 Metabolomics Mixes and Kits Industry Trends
  2. 2.2 Metabolomics Mixes and Kits Industry Drivers
  3. 2.3 Metabolomics Mixes and Kits Industry Opportunities and Challenges
  4. 2.4 Metabolomics Mixes and Kits Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Metabolomics Mixes and Kits Market Perspective (2021-2032)
  2. 3.2 Global Metabolomics Mixes and Kits Growth Trends by Region
  3. 3.2.1 Global Metabolomics Mixes and Kits Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Metabolomics Mixes and Kits Market Size by Region (2021-2026)
  5. 3.2.3 Global Metabolomics Mixes and Kits Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Metabolomics Mixes and Kits Revenue by Players
  2. 4.1.1 Global Metabolomics Mixes and Kits Revenue by Players (2021-2026)
  3. 4.1.2 Global Metabolomics Mixes and Kits Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Metabolomics Mixes and Kits Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Metabolomics Mixes and Kits Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Metabolomics Mixes and Kits Key Players Headquarters & Area Served
  7. 4.4 Global Metabolomics Mixes and Kits Players, Product Type & Application
  8. 4.5 Global Metabolomics Mixes and Kits Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Metabolomics Mixes and Kits Market CR5 and HHI
  11. 4.6.3 2025 Metabolomics Mixes and Kits Tier 1, Tier 2, and Tier 3
5 Metabolomics Mixes and Kits Market Size by Type
  1. 5.1 Global Metabolomics Mixes and Kits Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Metabolomics Mixes and Kits Revenue by Type (2021-2032)
  3. 5.3 Global Metabolomics Mixes and Kits Revenue Market Share by Type (2021-2032)
6 Metabolomics Mixes and Kits Market Size by Application
  1. 6.1 Global Metabolomics Mixes and Kits Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Metabolomics Mixes and Kits Revenue by Application (2021-2032)
  3. 6.3 Global Metabolomics Mixes and Kits Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cambridge Isotope Laboratories
  2. 7.1.1 Cambridge Isotope Laboratories Company Information
  3. 7.1.2 Cambridge Isotope Laboratories Business Overview
  4. 7.1.3 Cambridge Isotope Laboratories Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cambridge Isotope Laboratories Metabolomics Mixes and Kits Product Portfolio
  6. 7.1.5 Cambridge Isotope Laboratories Recent Developments
  7. 7.2 Merck KGaA
  8. 7.2.1 Merck KGaA Company Information
  9. 7.2.2 Merck KGaA Business Overview
  10. 7.2.3 Merck KGaA Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck KGaA Metabolomics Mixes and Kits Product Portfolio
  12. 7.2.5 Merck KGaA Recent Developments
  13. 7.3 Biocrates
  14. 7.3.1 Biocrates Company Information
  15. 7.3.2 Biocrates Business Overview
  16. 7.3.3 Biocrates Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Biocrates Metabolomics Mixes and Kits Product Portfolio
  18. 7.3.5 Biocrates Recent Developments
  19. 7.4 Thermo Fisher Scientific
  20. 7.4.1 Thermo Fisher Scientific Company Information
  21. 7.4.2 Thermo Fisher Scientific Business Overview
  22. 7.4.3 Thermo Fisher Scientific Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Metabolomics Mixes and Kits Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Recent Developments
  25. 7.5 Fluidome
  26. 7.5.1 Fluidome Company Information
  27. 7.5.2 Fluidome Business Overview
  28. 7.5.3 Fluidome Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Fluidome Metabolomics Mixes and Kits Product Portfolio
  30. 7.5.5 Fluidome Recent Developments
  31. 7.6 Metabolomix
  32. 7.6.1 Metabolomix Company Information
  33. 7.6.2 Metabolomix Business Overview
  34. 7.6.3 Metabolomix Metabolomics Mixes and Kits Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Metabolomix Metabolomics Mixes and Kits Product Portfolio
  36. 7.6.5 Metabolomix Recent Developments
8 North America
  1. 8.1 North America Metabolomics Mixes and Kits Revenue (2021-2032)
  2. 8.2 North America Metabolomics Mixes and Kits Revenue by Type (2021-2032)
  3. 8.2.1 North America Metabolomics Mixes and Kits Revenue by Type (2021-2026)
  4. 8.2.2 North America Metabolomics Mixes and Kits Revenue by Type (2027-2032)
  5. 8.3 North America Metabolomics Mixes and Kits Revenue Share by Type (2021-2032)
  6. 8.4 North America Metabolomics Mixes and Kits Revenue by Application (2021-2032)
  7. 8.4.1 North America Metabolomics Mixes and Kits Revenue by Application (2021-2026)
  8. 8.4.2 North America Metabolomics Mixes and Kits Revenue by Application (2027-2032)
  9. 8.5 North America Metabolomics Mixes and Kits Revenue Share by Application (2021-2032)
  10. 8.6 North America Metabolomics Mixes and Kits Revenue by Country
  11. 8.6.1 North America Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Metabolomics Mixes and Kits Revenue by Country (2021-2026)
  13. 8.6.3 North America Metabolomics Mixes and Kits Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Metabolomics Mixes and Kits Revenue (2021-2032)
  2. 9.2 Europe Metabolomics Mixes and Kits Revenue by Type (2021-2032)
  3. 9.2.1 Europe Metabolomics Mixes and Kits Revenue by Type (2021-2026)
  4. 9.2.2 Europe Metabolomics Mixes and Kits Revenue by Type (2027-2032)
  5. 9.3 Europe Metabolomics Mixes and Kits Revenue Share by Type (2021-2032)
  6. 9.4 Europe Metabolomics Mixes and Kits Revenue by Application (2021-2032)
  7. 9.4.1 Europe Metabolomics Mixes and Kits Revenue by Application (2021-2026)
  8. 9.4.2 Europe Metabolomics Mixes and Kits Revenue by Application (2027-2032)
  9. 9.5 Europe Metabolomics Mixes and Kits Revenue Share by Application (2021-2032)
  10. 9.6 Europe Metabolomics Mixes and Kits Revenue by Country
  11. 9.6.1 Europe Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Metabolomics Mixes and Kits Revenue by Country (2021-2026)
  13. 9.6.3 Europe Metabolomics Mixes and Kits Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Metabolomics Mixes and Kits Revenue (2021-2032)
  2. 10.2 China Metabolomics Mixes and Kits Revenue by Type (2021-2032)
  3. 10.2.1 China Metabolomics Mixes and Kits Revenue by Type (2021-2026)
  4. 10.2.2 China Metabolomics Mixes and Kits Revenue by Type (2027-2032)
  5. 10.3 China Metabolomics Mixes and Kits Revenue Share by Type (2021-2032)
  6. 10.4 China Metabolomics Mixes and Kits Revenue by Application (2021-2032)
  7. 10.4.1 China Metabolomics Mixes and Kits Revenue by Application (2021-2026)
  8. 10.4.2 China Metabolomics Mixes and Kits Revenue by Application (2027-2032)
  9. 10.5 China Metabolomics Mixes and Kits Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Metabolomics Mixes and Kits Revenue (2021-2032)
  2. 11.2 Asia Metabolomics Mixes and Kits Revenue by Type (2021-2032)
  3. 11.2.1 Asia Metabolomics Mixes and Kits Revenue by Type (2021-2026)
  4. 11.2.2 Asia Metabolomics Mixes and Kits Revenue by Type (2027-2032)
  5. 11.3 Asia Metabolomics Mixes and Kits Revenue Share by Type (2021-2032)
  6. 11.4 Asia Metabolomics Mixes and Kits Revenue by Application (2021-2032)
  7. 11.4.1 Asia Metabolomics Mixes and Kits Revenue by Application (2021-2026)
  8. 11.4.2 Asia Metabolomics Mixes and Kits Revenue by Application (2027-2032)
  9. 11.5 Asia Metabolomics Mixes and Kits Revenue Share by Application (2021-2032)
  10. 11.6 Asia Metabolomics Mixes and Kits Revenue by Country
  11. 11.6.1 Asia Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Metabolomics Mixes and Kits Revenue by Country (2021-2026)
  13. 11.6.3 Asia Metabolomics Mixes and Kits Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Metabolomics Mixes and Kits Revenue (2021-2032)
  2. 12.2 SAMEA Metabolomics Mixes and Kits Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Metabolomics Mixes and Kits Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Metabolomics Mixes and Kits Revenue by Type (2027-2032)
  5. 12.3 SAMEA Metabolomics Mixes and Kits Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Metabolomics Mixes and Kits Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Metabolomics Mixes and Kits Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Metabolomics Mixes and Kits Revenue by Application (2027-2032)
  9. 12.5 SAMEA Metabolomics Mixes and Kits Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Metabolomics Mixes and Kits Revenue by Country
  11. 12.6.1 SAMEA Metabolomics Mixes and Kits Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Metabolomics Mixes and Kits Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Metabolomics Mixes and Kits Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst